Nefopam hydrochloride

This classification denotes a benzodiazepine with the molecular formula C17H19NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 685J48E13W, chemically known as 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1h-2,5-benzoxazocine hydrochloride but more generally known as nefopam hydrochloride, which bears US NIH Compound Identifier 31872. European Medicines Agency schedules Nefopam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03400MIG. Most nations, for tariff and trade purposes, schedule nefopam hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, NEFOPAM HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Nefopam hydrochloride bears US NLM identifiers UMLS ID C0015820 and NCI Concept Code C83995. SMILES: CN1CCOC(C2CCCCC2C1)C3CCCCC3.CL.